02-03 March 2022
Wed-Thurs
Munich, Germany

15th Drug Discovery

Innovation Programme

About Drug Discovery Innovation Programme 2022





Join us in March 2022 to experience 2-days of top-level strategic content and the current scientific insights, networking, and discussions from leading global pharmaceutical R&D executives.
With over 100+ attendees, learn how new technologies and innovative processes are fundamentally changing what the drug discovery research will look like in the next two to five years.
This year’s Drug Discovery Innovation Programme will highlight the challenges discovery pipelines have faced due to COVID-19 and will put a spotlight on the adoption of technology to combat these.

Drug Discovery Innovation Programme Key Topics

ROAD TO AI

LEAD GENERATION STRATEGIES

BOOSTING IMMUNOTHERAPY

ADVANCES IN DRUG DESIGN

RNA THERAPEUTICS ON THE RISE

SMALL MOLECULES IN DRUG DISCOVERY

TRANSLATING OMICS INTO THERAPEUTICS

PRECLINICAL STRATEGIES, MODELS AND TOOLS

COLLABORATE TO ACCELERATE

HIT TRIAGE AND VALIDATION STRATEGIES

MEDICINAL CHEMISTRY TOOLBOX

NOVEL DRUG TARGET DISCOVERY & VALIDATION




Why Attend Drug Discovery Innovation Programme





Reconnecting with Peers
Have you ever experienced the situation where working through a challenge over email, conference calls or other distance communication channels seems to take a lot of back and forth with no resolution in sight?


Meeting New Prospects
If your goal at an industry event is to meet new prospective clients and partners, there is really no substitute for the in-person experience. Attend WBI’s in-person conferences to meet new prospects and build your clientage.


Brand Building
If part of your company’s brand positioning is to be a true leader in the industry, attending World BI’s events can be a powerful way to send that message.




Getting a Handle on the Market
While virtual events can certainly deliver planned content (sessions, presentations, panel discussions, etc.) quite well, you will still need to meet your peers in-person to get a handle on the current market news.


Driving New Business
Even in industries with longer sales cycles, World BI’s in-person events is the place where new business deals are completed.


Enhance Engagement
WBI’s in-person events will help bring decision makers on your table by identifying their requirements and tailoring your services to offer the most relevant and valuable services to them and thus boosting engagement.
0

Discussion Topics

0

Speakers

0

Attendees

0

Networking Hours

Experts Panel 2022

Meet our professonals



Jonathan

Jonathan Mason

Senior Research Fellow, Computational Chemistry

Orexia Therapeutics

Cristina

Cristina Mayor-Ruiz

Group Leader

IRB Barcelona

Dan Bach Kristensen

Principal Scientist

Symphogen

Iris

Iris Alroy

VP R&D

Anima Biotech

Eric

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

Catherine

Catherine Alix-Panabieres

Associate professor of Medicine

University of Montpellier

Patrize

Patrizia D'Alessio

CEO

AISA Therapeutics

Katarzyna

Katarzyna Derwińska

Leader of Pre-Clinical and Clinical Research, PM

WPD Pharmaceuticals

Marisol

Marisol Montolio

Scientific Director

Duchenne Parent Project Spain

Fradoon

Fraydoon Rastinejad

Professor of Biochemistry and Structural Biology

University of Oxford, Nuffield Department of Medicine

John Doe

Stefan Zielonka

Associate Director, Protein Engineering & Antibody Technologies

Merck KGaA

John Doe

Philippe Moingeon

Head of Therapeutic Area Immuno-Inflammation, Application of AI to Drug Development

Servier Pharmaceuticals

Who Will Attend

Delegates Will Include VPs, CEOs, CSOs, CTOs, Global Heads, Directors, Managers



Bioinformatics
Innovation
Research
R&D Senior Scientist
Computational Chemist
Principal Research Scientist
Data Scientist
Non-Clinical Development
Biology
Early Development
Non-Clinical Biostatistics
Intelligent Systems Laboratory
Translational Immunology
Pharmaceutical Research
Discovery R&D
Senior Scientist
Medical Chemistry
Analytical Sciences
Machine Learning Research
Translational oncology

Expert Interview



John Doe

Krishna Kanumuri

CEO

SAI LIFE SCIENCES LTD

View Complete Interview
TESTIMONIALS

what people say

One-on one meetings are very good, very informal, relax and gives you very nice partnering opportunities.


Co-Founder 3Z ehf
I've been able to meet people, potential customers and partners. The event saves you time and effort especially for the networking and the business development in our case.
Sr. Director of business Development. Nuchem Therapeutics
I liked the networking where you could meet lot of people and have one-on-one meeting.



VP Pharmacology TocopheR

Exquisite Venue

Munich

Our Partners

We have Partners not Sponsors



Events Gallery

see what we did lately

"
Book with us

@example.com